@article{fb19599ce4d048c587cc76f51e56b98d,
title = "Antimicrobial stewardship in ICUs during the COVID-19 pandemic: back to the 90s?",
keywords = "Anti-Bacterial Agents/therapeutic use, Antimicrobial Stewardship, COVID-19/therapy, Critical Care, Humans, Intensive Care Units/organization & administration, SARS-CoV-2",
author = "{De Waele}, {Jan J} and Lennie Derde and Matteo Bassetti",
note = "Funding Information: JDW: grant from the Flanders Research Foundation (Senior Clinical Investigator Grant); consulted for Accelerate, Bayer Healthcare, Grifols, MSD, Pfizer (honoraria were paid to his institution). LD: none. MB: outside the submitted work, MB has participated in advisory boards and/or received speaker honoraria from Achaogen, Angelini, Astellas, Bayer, Basilea, BioM{\'e}rieux, Cidara, Gilead, Menarini, MSD, Nabriva, Paratek, Pfizer, Roche, Melinta, Shionogi, Tetraphase, VenatoRx and Vifor and has received study grants from Angelini, Basilea, Astellas, Shionogi, Cidara, Melinta, Gilead, Pfizer and MSD. ",
year = "2021",
month = jan,
doi = "10.1007/s00134-020-06278-x",
language = "English",
volume = "47",
pages = "104--106",
journal = "Intensive Care Medicine",
issn = "0342-4642",
publisher = "Springer-Verlag",
number = "1",
}